Unichem Laboratories Limited

NSE UNICHEMLAB.NS

Unichem Laboratories Limited Free Cash Flow Yield on February 07, 2025: -0.12%

Unichem Laboratories Limited Free Cash Flow Yield is -0.12% on February 07, 2025, a 96.50% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Unichem Laboratories Limited 52-week high Free Cash Flow Yield is -0.09% on November 08, 2024, which is 22.50% above the current Free Cash Flow Yield.
Unichem Laboratories Limited 52-week low Free Cash Flow Yield is -3.86% on March 27, 2024, which is -3,118.33% below the current Free Cash Flow Yield.
Unichem Laboratories Limited average Free Cash Flow Yield for the last 52 weeks is -0.61%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: UNICHEMLAB.NS

Unichem Laboratories Limited

CEO	Mr. Scott B. Delaney
IPO Date	July 1, 2002
Location	India
Headquarters	Unichem Bhavan
Employees	2,875
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Drugstores & Retail Pharmacies Personal Care

Description

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.

Key trends

Past 5 years